カテゴリ： 世界, 医療/バイオ, Bizwit Research & Consulting

潜在性結核感染検出のグローバル市場（2022年-2029年）：ツベルクリン皮膚検査、インターフェロンγ遊離検査

■ 英語タイトル：Global Latent Tuberculosis Infection Detection Market Size study & Forecast, by Test Type (Tuberculin Skin Test, Interferon Gamma Release Assays), by End-User (Diagnostic Laboratories, Hospitals/Clinics, Academic & Research Institutions) and Regional Analysis, 2022-2029

調査会社Bizwit Research & Consulting社が発行したリサーチレポート（データ管理コード：BZW23FE0014）■ 発行会社/調査会社：Bizwit Research & Consulting
■ 商品コード：BZW23FE0014
■ 発行日：2023年2月8日
■ 調査対象地域：アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東
■ 産業分野：医療
■ ページ数：約200
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用、印刷不可）USD4,950 ⇒換算￥732,600見積依頼/購入/質問フォーム
Enterprisewide（同一法人内共有可）USD6,250 ⇒換算￥925,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Bizwit Research & Consulting社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[潜在性結核感染検出のグローバル市場（2022年-2029年）：ツベルクリン皮膚検査、インターフェロンγ遊離検査]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Bizwit Research社の本調査資料では、2021年にXX億ドルであった世界の潜在性結核感染検出市場規模が、2022年〜2029年にかけてXX%で成長すると予測しています。本資料は、潜在性結核感染検出の世界市場について市場実態を明らかにするとともに、今後の動向を展望したレポートです。エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、検査別（ツベルクリン皮膚検査、インターフェロンγ遊離検査）分析、エンドユーザー別（診断検査室、病院/クリニック、学術・研究機関）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、その他）分析、競争分析、調査プロセスなどの項目で構成されています。また、主要参入企業として、QIAGEN N.V.、Oxford Immunotec Inc.、F. Hoffmann-La Roche Ltd.、Sanofi S.A.、Abbott Laboratories、bioMérieux SA、Becton, Dickinson, and Company、Endo International plc、PerkinElmer, Inc.、Bruker Corporationなどの情報が含まれています。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・リスク分析（新型コロナウイルス感染症の影響）
・世界の潜在性結核感染検出市場規模：検査別
- ツベルクリン皮膚検査の市場規模
- インターフェロンγ遊離検査の市場規模
・世界の潜在性結核感染検出市場規模：エンドユーザー別
- 診断検査室における市場規模
- 病院/クリニックにおける市場規模
- 学術・研究機関における市場規模
・世界の潜在性結核感染検出市場規模：地域別
- 北米の潜在性結核感染検出市場規模
- ヨーロッパの潜在性結核感染検出市場規模
- アジア太平洋の潜在性結核感染検出市場規模
- 中南米の潜在性結核感染検出市場規模
- その他地域の潜在性結核感染検出市場規模
・競争分析
・調査プロセス

Global Latent Tuberculosis Infection Detection Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Latent Tuberculosis Infection (LTBI) is a variety of TB infection in which bacteria remains inactive specifically bacteria that exists in the sleeping state inside the individual’s body. The detection of this infection is identified by the tuberculin skin test (TST). The risk is increased by other diseases including drug abuse, HIV, or medications that weakens the immune system. Factors such as surging demand for tuberculosis testing, growing funding to manage disease treatment, and increasing geriatric population are driving the market growth globally.

The rising risk of developing active TB from latent tuberculosis infection (LTBI) is propelling the demand for market across the globe. According to TBFacts.org, in 2021, about 40% of Indians are estimated to be infected with the TB bacteria, with the great majority having latent TB instead of active TB disease. Likewise, according to the Centers for Disease Control and Prevention report 2021, it was estimated that up to 13 million people in the United States suffered from latent TB infection. Therefore, the high prevalence rate of latent tuberculosis infection among the population is augmenting the market growth. Furthermore, growing awareness campaigns conducted by non-government bodies and market players, as well as a rising number of government initiatives to treat LTBI are leveraging multiple opportunities in the foreseen years. However, the lack of a systematic approach to screening tuberculosis and the unavailability of proper recommendations and reimbursement policies are hindering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Latent Tuberculosis Infection Detection Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the growing awareness about early diagnosis of infection, high funding for tuberculosis management, and improvement of healthcare facilities. Whereas, Asia Pacific is expected to grow at the highest CAGR during the forecast period. Factors such as high infection rates in developing countries, increasing population, as well as government favorable initiatives are burgeoning the market growth in the forecasting years.

Major market players included in this report are:
QIAGEN N.V.
Oxford Immunotec Inc.
F. Hoffmann-La Roche Ltd.
Sanofi S.A.
Abbott Laboratories
bioMérieux SA
Becton, Dickinson, and Company
Endo International plc
PerkinElmer, Inc.
Bruker Corporation
Recent Developments in the Market:
 In February 2022, QIAGEN N.V. announced that the company received approval for its QuantiFERON tuberculosis testing solution in China. With this strategic initiative company aims to boost its market share across the region.

Global Latent Tuberculosis Infection Detection Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Test Type, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Test Type:
Tuberculin Skin Test
Interferon Gamma Release Assays

By End User:
Diagnostic Laboratories
Hospitals/Clinics
Academic & Research Institutions

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World

*** レポート目次（コンテンツ）***

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Latent Tuberculosis Infection Detection Market, by Region, 2019-2029 (USD Billion)
1.2.2. Latent Tuberculosis Infection Detection Market, by Test Type, 2019-2029 (USD Billion)
1.2.3. Latent Tuberculosis Infection Detection Market, by End-User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Latent Tuberculosis Infection Detection Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Latent Tuberculosis Infection Detection Market Dynamics
3.1. Latent Tuberculosis Infection Detection Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Rising risk of developing active TB from latent tuberculosis infection (LTBI)
3.1.1.2. Surging demand for tuberculosis testing
3.1.2. Market Challenges
3.1.2.1. Lack of a systematic approach to screening tuberculosis
3.1.2.2. Unavailability of proper recommendations and reimbursement policies
3.1.3. Market Opportunities
3.1.3.1. Growing awareness campaigns conducted by non-government bodies and market players
3.1.3.2. Rising number of government initiatives to treat LTBI
Chapter 4. Global Latent Tuberculosis Infection Detection Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological

4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Latent Tuberculosis Infection Detection Market, by Test Type
6.1. Market Snapshot
6.2. Global Latent Tuberculosis Infection Detection Market by Test Type, Performance – Potential Analysis
6.3. Global Latent Tuberculosis Infection Detection Market Estimates & Forecasts by Test Type 2019-2029 (USD Billion)
6.4. Latent Tuberculosis Infection Detection Market, Sub Segment Analysis
6.4.1. Tuberculin Skin Test
6.4.2. Interferon Gamma Release Assays
Chapter 7. Global Latent Tuberculosis Infection Detection Market, by End-User
7.1. Market Snapshot
7.2. Global Latent Tuberculosis Infection Detection Market by End-User, Performance – Potential Analysis
7.3. Global Latent Tuberculosis Infection Detection Market Estimates & Forecasts by End-User 2019-2029 (USD Billion)
7.4. Latent Tuberculosis Infection Detection Market, Sub Segment Analysis
7.4.1. Diagnostic Laboratories
7.4.2. Hospitals/Clinics
7.4.3. Academic & Research Institutions
Chapter 8. Global Latent Tuberculosis Infection Detection Market, Regional Analysis
8.1. Latent Tuberculosis Infection Detection Market, Regional Market Snapshot
8.2. North America Latent Tuberculosis Infection Detection Market
8.2.1. U.S. Latent Tuberculosis Infection Detection Market
8.2.1.1. Test Type breakdown estimates & forecasts, 2019-2029
8.2.1.2. End-User breakdown estimates & forecasts, 2019-2029
8.2.2. Canada Latent Tuberculosis Infection Detection Market
8.3. Europe Latent Tuberculosis Infection Detection Market Snapshot
8.3.1. U.K. Latent Tuberculosis Infection Detection Market
8.3.2. Germany Latent Tuberculosis Infection Detection Market
8.3.3. France Latent Tuberculosis Infection Detection Market
8.3.4. Spain Latent Tuberculosis Infection Detection Market
8.3.5. Italy Latent Tuberculosis Infection Detection Market
8.3.6. Rest of Europe Latent Tuberculosis Infection Detection Market
8.4. Asia-Pacific Latent Tuberculosis Infection Detection Market Snapshot
8.4.1. China Latent Tuberculosis Infection Detection Market
8.4.2. India Latent Tuberculosis Infection Detection Market
8.4.3. Japan Latent Tuberculosis Infection Detection Market
8.4.4. Australia Latent Tuberculosis Infection Detection Market
8.4.5. South Korea Latent Tuberculosis Infection Detection Market
8.4.6. Rest of Asia Pacific Latent Tuberculosis Infection Detection Market
8.5. Latin America Latent Tuberculosis Infection Detection Market Snapshot
8.5.1. Brazil Latent Tuberculosis Infection Detection Market
8.5.2. Mexico Latent Tuberculosis Infection Detection Market
8.5.3. Rest of Latin America Latent Tuberculosis Infection Detection Market
8.6. Rest of The World Latent Tuberculosis Infection Detection Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. QIAGEN N.V.
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Product Summary
9.2.1.5. Recent Developments
9.2.2. Oxford Immunotec Inc.
9.2.3. F. Hoffmann-La Roche Ltd.
9.2.4. Sanofi S.A.
9.2.5. Abbott Laboratories
9.2.6. bioMérieux SA
9.2.7. Becton, Dickinson, and Company
9.2.8. Endo International plc
9.2.9. PerkinElmer, Inc.
9.2.10. Bruker Corporation
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

List of Tables
TABLE 1. Global Latent Tuberculosis Infection Detection Market, report scope
TABLE 2. Global Latent Tuberculosis Infection Detection Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Latent Tuberculosis Infection Detection Market estimates & forecasts by Test Type 2019-2029 (USD Billion)
TABLE 4. Global Latent Tuberculosis Infection Detection Market estimates & forecasts by End-User 2019-2029 (USD Billion)
TABLE 5. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Latent Tuberculosis Infection Detection Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Latent Tuberculosis Infection Detection Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Latent Tuberculosis Infection Detection Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Latent Tuberculosis Infection Detection Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Latent Tuberculosis Infection Detection Market
TABLE 70. List of primary sources, used in the study of global Latent Tuberculosis Infection Detection Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 肺炎検査のグローバル市場（2022年-2029年）：器具、試薬・消耗品
  • 精液分析のグローバル市場（2022年-2029年）：精液分析装置、サンプル調製用遠心分離機、精液検査キット、使い捨て用品・消耗品、ソフトウェア
  • 結合型ワクチンのグローバル市場（2022年-2029年）：一価結合型ワクチン、多価結合型ワクチン
  • アフェレシスのグローバル市場（2022年-2029年）：機器、消耗品・試薬、ソフトウェア
  • 放射線治療装置のグローバル市場（2022年-2029年）：外部照射型放射線治療装置、内部照射型放射線治療装置、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(BZW23FE0014 )"潜在性結核感染検出のグローバル市場（2022年-2029年）：ツベルクリン皮膚検査、インターフェロンγ遊離検査" (英文：Global Latent Tuberculosis Infection Detection Market Size study & Forecast, by Test Type (Tuberculin Skin Test, Interferon Gamma Release Assays), by End-User (Diagnostic Laboratories, Hospitals/Clinics, Academic & Research Institutions) and Regional Analysis, 2022-2029)はBizwit Research & Consulting社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。